Document is current
Any future updates will be listed below
-
Authors
Xu, Fengwen
Huang, Yu
Hou, Yongzhi
Xie, Yu
Huang, Baoying
Zhao, Fei
Gao, Zhao
Chen, Chen
Wang, Jiaxun
Mei, Shan
Hu, Yamei
Wang, Liming
Wei, Liang
Zhang, Jingjing
Li, Na
Cong, Zhe
Ma, Jianrong
Zhu, Lin
Chen, Ting
Lu, Jiahan
Wei, Qiang
Tan, Wenjie
Xue, Jing
Guo, Fei
-
Funding
Funding for this research was provided by:
National Key R&D Program of China (2023YFC2307902)
National Natural Science Foundation of China (32200718, 82241075)
CAMS Innovation Fund for Medical Sciences (CIFMS 2022-I2M-1-021, CIFMS 2021-I2M-1-038)
- License Information
-
More Information
Article History
Received: 11 February 2025
Accepted: 11 June 2025
First Online: 1 July 2025
Competing interests
: F.G., F.X., Y.H. and S.M. are inventors on pending and issued patents on mpox vaccine. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationship that could be constructed as a potential conflict of interest.
